Understanding financial conflicts of interest.

  title={Understanding financial conflicts of interest.},
  author={D. F. Thompson},
  journal={The New England journal of medicine},
  volume={329 8},
  • D. Thompson
  • Published 19 August 1993
  • Medicine, Political Science
  • The New England journal of medicine
The problem of conflicts of interest began to receive serious attention in the medical literature in the 1980s1,2. Studies have described a wide range of conflicts involving physicians, medical researchers, and medical institutions (the most comprehensive is by Rodwin3). Among the areas of concern are self-referral by physicians,4–6 physicians' risk sharing in health maintenance organizations (HMOs) and hospitals,7 gifts from drug companies to physicians,8,9 hospital purchasing and bonding… 

Institutional conflict of interest.

Relative inattention persists despite the increased pressure on health care institutions to seek new sources of revenue to fund their activities and the government's encouragement of the .

Conflict of interest in clinical practice.

Recognition and acknowledgment are the first steps in ameliorating conflicts of interest, which can then be disclosed and potentially eliminated.

Financial conflicts of interest in biomedical research.

Financial conflicts of interest in medicine -- what they are and how to deal with them -- constitute one of the most contentious issues in our profession. Organized medicine and its critics have

Managing financial and nonfinancial conflicts of interest in healthcare delivery.

Various types of conflicts that can and do occur in healthcare delivery are discussed and potential policy options that may address these issues are discussed.

Conflict of Interest

An overview of the problems arising from complex relationships between industry, investigators, and academic institutions have evolved inevitably resulting in various ethical challenges is presented.

Conflict of interest in clinical research

  • R. Ghooi
  • Political Science
    Perspectives in clinical research
  • 2015
It is admitted that conflicts cannot be done away with, but their timely identification, disclosure, and management can reduce their impact and bring more transparency and accountability to trials in this country.

Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.

  • D. Schetky
  • Political Science, Medicine
    Child and adolescent psychiatric clinics of North America
  • 2008

Intrinsic Conflicts of Interest in Clinical Research: A Need for Disclosure

Conflicts of interest arise in all clinical research endeavors as a result of the tension among professionals' responsibilities to their research and to their patients and both academic and financial incentives.

Evaluate the adequacy of disclosure as a solution to the problem of conflict of interest in medical research

For clinical researchers, the demands of the pharmaceutical and medical marketplace may exert an undue influence on clinical trials and other processes, through the desire of commercial interests to generate an outcome that is favourable to their interests.



Conflicts of interest. Physician ownership of medical facilities. Council on Ethical and Judicial Affairs, American Medical Association.

The Council on Ethical and Judicial Affairs revisits the question of referral of patients to medical facilities in which physicians have financial interests and concludes that, in general, physicians should not refer patients to a health care facility outside their office practice when they have an investment interest in the facility.

Physicians' Conflicts of Interest: The Limitations of Disclosure

  • M. Rodwin
  • Medicine
    The New England journal of medicine
  • 1989
Examination of disclosure policies in four other contexts - medical informed consent, consumer-protection laws, disclosure by lawyers to clients, and disclosure by government officials - and their implications and limitations as models for disclosing physicians' conflicts of interest are examined.

Dealing with conflicts of interest.

  • A. Relman
  • Medicine
    The New England journal of medicine
  • 1985
Connections between industry and academic medical scientists are not new, but as the commercial possibilities of new biomedical discoveries have become increasingly attractive, these connections have become more pervasive, complex, and problematic.

Conflict of interest. The new McCarthyism in science.

Disclosure policies are supposed to reduce problems of scientific misconduct ranging from sloppiness to fraud by allowing readers to make a more informed and therefore a better interpretation of published work.

Conflict of interest and the BMJ

Conflict of interest may also arise with letters, and many letters that seem to come from individuals who simply have an interest in the subject are in fact prompted by organisations with an interest, financial or otherwise, in the outcome of the correspondence.

How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organizations?

The use of some, but not all, financial incentives, as well as the type of HMO, does influence the behavior of physicians toward patients, and it remains to be determined how these factors affect the quality of care.

The journal's policy on cost-effectiveness analyses.

Concern about cost now dominates many decisions about the use of drugs and other therapeutic interventions, and published economic analyses that relate the effectiveness of treatments and their associated costs (cost-effectiveness analyses).

The new medical-industrial complex.

  • A. Relman
  • Medicine, Political Science
    The New England journal of medicine
  • 1981
Closer attention from the public and the profession, and careful study, are necessary to ensure that the "medical-industrial complex" puts the interests of the pub...

Must the law assure ethical behavior?

It is not surprising that physicians would look for ways to enhance the availability of all this burgeoning technology by reducing the volume of care given by reducing individual reimbursement: a shaky hypothesis at best.

Physician Self Referral Arrangements: Legitimate Business or Unethical “Entrepreneurialism”

  • T. N. McDowell
  • Political Science, Medicine
    American Journal of Law & Medicine
  • 1989
An effective legal or ethical response to self referral arrangements must acknowledge and balance both the possible pro-competitive effects of such arrangements and the inherent potential for abuses in this type of business practice.